A cross-disease blood-based biomarker that is highly sensitive to neuronal damage is neurofilament light chain (NfL), which has been associated with disease severity and prognosis in multiple neurological diseases and general neurodegeneration7–9. The gene discussed is NEFL; the disease is nervous system disorder.